Valeant Settles One Legal Headache But Still Faces Congressional, DOJ Probes
This article was originally published in The Pink Sheet Daily
Valeant gets payment from R&O Pharmacy in litigation settlement as House Oversight Committee presses firm to explain why it is withholding certain documents.
You may also be interested in...
Specialty mail-order pharmacy Philidor was held up as an example of how Valeant was bilking patients when the usually close arrangement initially came to light; now it seems that Valeant itself was allegedly getting bilked.
Members of House Oversight Committee accuse Turing and Valeant of 'trashing' mainstream innovator companies with their drug pricing practices.
Neither has announced a firm timeline, and the difference between Pfizer's 'October' and Moderna's 'November' could be mere hours or a few weeks, but Pfizer, by dint of luck or experience, is now in a position to offer the more optimistic projection on when it will seek an EUA. Both firms release their Phase III trial protocols, which seem in line with US FDA guidance.